InspireMD Inc (NSPR)
2.141
-0.07
(-3.13%)
USD |
NASDAQ |
Apr 18, 16:00
2.12
-0.02
(-0.98%)
Pre-Market: 20:00
InspireMD Enterprise Value: 11.20M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 11.20M |
| April 17, 2024 | 12.82M |
| April 16, 2024 | 13.75M |
| April 15, 2024 | 14.22M |
| April 12, 2024 | 15.40M |
| April 11, 2024 | 15.87M |
| April 10, 2024 | 13.05M |
| April 09, 2024 | 14.46M |
| April 08, 2024 | 15.93M |
| April 05, 2024 | 14.69M |
| April 04, 2024 | 14.69M |
| April 03, 2024 | 12.58M |
| April 02, 2024 | 11.41M |
| April 01, 2024 | 16.49M |
| March 28, 2024 | 16.57M |
| March 27, 2024 | 14.50M |
| March 26, 2024 | 13.75M |
| March 25, 2024 | 15.16M |
| March 22, 2024 | 16.57M |
| March 21, 2024 | 15.40M |
| March 20, 2024 | 15.16M |
| March 19, 2024 | 15.16M |
| March 18, 2024 | 14.22M |
| March 15, 2024 | 14.69M |
| March 14, 2024 | 17.27M |
| Date | Value |
|---|---|
| March 13, 2024 | 19.62M |
| March 12, 2024 | 18.68M |
| March 11, 2024 | 20.90M |
| March 08, 2024 | 22.67M |
| March 07, 2024 | 22.90M |
| March 06, 2024 | 20.32M |
| March 05, 2024 | 22.67M |
| March 04, 2024 | 17.11M |
| March 01, 2024 | 19.07M |
| February 29, 2024 | 21.04M |
| February 28, 2024 | 21.48M |
| February 27, 2024 | 20.60M |
| February 26, 2024 | 16.89M |
| February 23, 2024 | 18.41M |
| February 22, 2024 | 19.73M |
| February 21, 2024 | 17.86M |
| February 20, 2024 | 17.98M |
| February 16, 2024 | 18.75M |
| February 15, 2024 | 19.73M |
| February 14, 2024 | 19.51M |
| February 13, 2024 | 20.47M |
| February 12, 2024 | 20.82M |
| February 09, 2024 | 21.04M |
| February 08, 2024 | 21.26M |
| February 07, 2024 | 23.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.29M
Minimum
Nov 10 2022
133.02M
Maximum
Feb 11 2021
3.530M
Average
-1.453M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 855.25M |
| Retractable Technologies Inc | -14.09M |
| Xtant Medical Holdings Inc | 125.09M |
| Asensus Surgical Inc | 47.66M |
| Catheter Precision Inc | 0.2633M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.405M |
| Revenue (Quarterly) | 1.761M |
| Total Expenses (Quarterly) | 7.569M |
| EPS Diluted (Quarterly) | -0.13 |
| Gross Profit Margin (Quarterly) | 28.68% |
| Profit Margin (Quarterly) | -306.9% |
| Earnings Yield | -49.04% |
| Normalized Earnings Yield | -49.04 |